Dendritic cells of leukemic origin: specialized antigen-presenting cells as potential treatment tools for patients with myeloid leukemia
DC Amberger, HM Schmetzer - Transfusion Medicine and Hemotherapy, 2020 - karger.com
The prognosis of elderly patients with acute myeloid leukemia (AML) and high-grade
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia
DC Amberger, HM Schmetzer - … : offizielles Organ der …, 2020 - pubmed.ncbi.nlm.nih.gov
The prognosis of elderly patients with acute myeloid leukemia (AML) and high-grade
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia.
DC Amberger, HM Schmetzer - Transfusion Medicine and …, 2020 - europepmc.org
The prognosis of elderly patients with acute myeloid leukemia (AML) and high-grade
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
[HTML][HTML] Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia
DC Amberger, HM Schmetzer - Transfusion Medicine and …, 2020 - ncbi.nlm.nih.gov
The prognosis of elderly patients with acute myeloid leukemia (AML) and high-grade
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia
DC Amberger, HM Schmetzer - Transfusion Medicine and Hemotherapy, 2020 - karger.com
The prognosis of elderly patients with acute myeloid leukemia (AML) and high-grade
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia.
DC Amberger, HM Schmetzer - Transfusion Medicine & …, 2020 - search.ebscohost.com
The prognosis of elderly patients with acute myeloid leukemia (AML) and high-grade
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
Dendritic Cells of Leukemic Origin: Specialized Antigen-Presenting Cells as Potential Treatment Tools for Patients with Myeloid Leukemia
DC Amberger, HM Schmetzer - Transfusion Medicine …, 2020 - epub.ub.uni-muenchen.de
The prognosis of elderly patients with acute myeloid leukemia (AML) and high-grade
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …
myelodysplastic syndrome (MDS) is limited due to the lack of therapy options and high …